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Abstract
Background: Exhaled nitric oxide (ENO) is elevated in bronchial asthma patients, and inhaled corticosteroid
therapy lowers the elevated ENO levels in such patients. ENO appears to be an inflammatory marker, but its role in
the pathophysiology of cough remains unclear. This study aimed to elucidate the relationship between NO and
increased cough reflex sensitivity induced by allergic airway reactions.
Methods: Cough reflex sensitivity to inhaled capsaicin was observed under NO depletion caused by NO synthase
(NOS) inhibitors in non-sensitized and ovalbumin (OVA)-sensitized guinea pigs. The bronchoalveolar lavage fluid
(BALF) was analyzed in an NO depletion setting using the inducible NOS (iNOS) inhibitor ONO1714 in OVA-
sensitized guinea pigs.
Results: NO depletion by the non-selective NOS inhibitor L-NAME suppressed cough reflex sensitivity in non-
sensitized guinea pigs and OVA-induced increase in cough reflex sensitivity in sensitized guinea pigs; however,
iNOS inhibition caused by ONO1714 partially suppressed the OVA-induced increase in cough reflex sensitivity, but
not the normal cough response in non-sensitized guinea pigs. ONO1714 did not change BAL cell components in
OVA-sensitized guinea pigs.
Conclusions: The results suggest that NO may be involved not only in the normal cough reflex circuit, but also in
the OVA-induced increase in cough reflex sensitivity, possibly via a different mechanism of action. Further studies
are needed to clarify the precise mechanism.
Background
Nitric oxide (NO) may play an essential role in regulat-
ing airway function and in the pathophysiology of
inflammatory airway diseases [1]. NO is generated by
NO synthase (NOS) from L-arginine in vivo [2]. NOS
has three isoforms, namely neuronal NOS (nNOS: NOS-
1), endothelial NOS (eNOS: NOS-3), and inducible NOS
(iNOS: NOS-2) [2-6]. The former two isoforms are con-
stitutive isozymes [7], and are assumed to regulate phy-
siological homeostasis. The latter NOS can produce a
much greater amount of NO than the constitutive forms
[8]. High concentrations of NO may have not only ben-
eficial functions (e.g. antibacterial, antiparasitic and
antiviral), but also detrimental results, such as endotoxin
shock [9], apoptosis [10], and pro-inflammatory effects
[11,12].
Exhaled nitric oxide (ENO) is at significantly elevated
levels in bronchial asthma patients compared to healthy
subjects [13]. Immunostaining of biopsied bronchial
mucosa has shown that iNOS is generally present in
much more amounts in the bronchial epithelium of
bronchial asthma patients than normal subjects [3]. Glu-
cocorticoids inhibit expression of iNOS, but not of
cNOS, in vascular endothelial cells [14]. These findings
indicate that the augmentation of ENO results from
increased iNOS expression in the airway of bronchial
asthma patients. Recently, ENO measurements are
recognized as a good surrogate marker for eosinophilic
airway inflammation [15]. De Diego et al. reported that
ENO levels in cough variant asthma patients were simi-
lar to those in bronchial asthma patients [16].
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has been reported in chronic cough associated with
eosinophilic airway inflammation, such as non-asthmatic
eosinophilic bronchitis [17], and atopic cough [18]. It is
still controversial in bronchial asthma [19,20]. No study
has investigated the relationship between cough reflex
sensitivity and NO. In this study, we hypothesized that
NO produced by iNOS might be a promoter in cough
reflex sensitivity, and therefore performed the iNOS
inhibition experiment using NOS inhibitors, in non-sen-
sitized guinea pigs with normal cough reflex sensitivity
and in OVA-sensitized guinea pigs which were of
increased cough reflex sensitivity associated with allergic
eosinophilic airway inflammation.
Methods
Animals
Male albino Hartley-strain guinea pigs (body weight,
450-500 g and 150-200 g), obtained from Sankyo
Laboratory Service (Toyama, Japan), were used in the
non-sensitized model experiment and in actively ovalbu-
min (OVA)-sensitized and -challenged model experi-
ments, respectively. They were quarantined at the
Animal Research Center of Kanazawa University. All
animal procedures in this study conformed to the stan-
d a r d ss e ti nt h eG u i d e l i n e sf o rt h eC a r ea n dU s eo f
Laboratory Animals at the Takara-machi campus of
Kanazawa University.
Experimental protocol
Experiment 1: NO depletion by the NOS inhibitor L-NAME
The experimental protocol schemes are shown in Figure
1 and 2.
Non-sensitized and OVA-sensitized guinea pigs were
divided into four groups: control (normal saline) group
and groups receiving the non-selective NOS inhibitor L-
NAME at doses of 3, 10, and 30 mg/kg (n = 6 for each
group). L-NAME was dissolved in physiological saline.
Vehicle (normal saline) and L-NAME solution were
intraperitoneally administered 0.5 h prior to the mea-
surement of cough reflex sensitivity to inhaled capsaicin.
Experiment 2: NO depletion by the selective iNOS inhibitor
ONO1714
The experimental protocol schemes are shown in Figure
1 and 3.
Non-sensitized and OVA-sensitized guinea pigs were
divided into three groups: control (normal saline) group
and groups receiving the selective iNOS inhibitor
ONO1714 at doses of 0.1 and 0.3 mg/kg (n = 6 for each
group). ONO1714 (1S,5R,6R,7R)-7-chloro-3-imino-5-
methyl-2-azabicyclo [4.1.0]heptane hydrochloride, a
fused piperidine derivative, is a competitive iNOS inhibi-
tor with a high safety margin (maximum tolerance dose
(MTD) = 30 mg/kg, i.v., MTD/50% inhibitory dose for
NOx accumulation = 3000 in mice) [21]; it was provided
by Ono Pharmaceutical Co. Ltd. (Osaka, Japan).
ONO1714 was dissolved in normal saline at doses of 0.1
and 0.3 mg/kg. Vehicle (normal saline) and ONO1714
solution were first intraperitoneally administered 0.5 h
prior to the measurement of cough reflex sensitivity to
inhaled capsaicin, and were again administered 0.5 h
prior to ENO measurement followed by bronchoalveolar
lavage (BAL), which was performed 24 h after the mea-
surement of cough reflex sensitivity.
Active sensitization and OVA challenge
Guinea pigs were OVA sensitized by the method
reported by Muraki et al [22]. Guinea pigs weighing
150-200 g were intraperitoneally administered with 2.0
mg of OVA and 100 mg of aluminum hydroxide [Al
(OH)3] two days after an intraperitoneal administration
of 30 mg/kg cyclophosphamide. Three weeks later,
boosting was performed by intraperitoneal administra-
tion of 0.01 mg of OVA and 100 mg of Al(OH)3.T h r e e
weeks after boosting, OVA sensitized guinea pigs were
challenged with an aerosolized OVA solution under
spontaneous breathing at 20 min after an intraperitoneal
administration of diphenhydramine (20 mg/kg) to avoid
acute anaphylactic respiratory distress. Conscious guinea
pigs were placed in a dual chamber plethysmograph
(head chamber volume, 1520 mL) (Model PMUA +
SAR, Buxco Electronics, Sharon, CT, USA). Guinea pigs
were challenged with 10 mg/mL OVA aerosol for 90 s
(head chamber only, 0.08 mL/min output). The aerosol
was generated using the DeVilbiss 646 nebulizer (DeVil-
biss Co., Somerset, PA, USA) operated by compressed
air at 7.57 L/min (Minipon 54B-588, Origin Medical
Vehicle, L-NAME or ONO1714
0.5 h
Measurement of 
1) cough reflex sensitivity
2) ENO measurement and BAL*
Figure 1 Experimental design for the effect of NOS inhibitors
in non-sensitized guinea pigs. Vehicle (normal saline), the NOS
inhibitor L-NAME solutions, or the iNOS inhibitor ONO1714 solutions
were administered 0.5 h prior to cough reflex sensitivity to capsaicin
and ENO measurement in non-sensitized guinea pigs weighing 500
to 550 g. *BAL was performed only in ONO1714 experiment.
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Figure 2 Experimental design for the effect of L-NAME in OVA sensitized guinea pigs.2 4ha f t e rO V Ac h a l l e n g e ,v e h i c l eo rL - N A M E
solutions were administered 0.5 h prior to cough reflex sensitivity to capsaicin and ENO measurement in OVA sensitized guinea pigs weighing
500 to 550 g.
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Figure 3 Experimental design for the effect of ONO1714 in OVA sensitized guinea pigs. 24 h after OVA challenge, vehicle or ONO1714
solutions were first administered 0.5 h prior to cough reflex sensitivity to capsaicin in OVA sensitized guinea pigs weighing 500 to 550 g, and
again administered 0.5 h prior to ENO measurement and BAL, which was performed 24 h after the cough reflex sensitivity.
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ity to inhaled capsaicin was measured in the guinea pigs
24 h after OVA challenge.
Cough reflex sensitivity to capsaicin
Cough reflex sensitivity was measured as described pre-
viously [23]. Capsaicin (30.5 mg) was dissolved in
Tween 80 (1 mL) and ethanol (1 mL) and then dissolved
in physiological saline (8 mL) to prepare a 10
-2 M stock
solution, which was stored at -20°C. This solution was
diluted with physiological saline to prepare 10
-6 and 10
-4
M solutions. Each conscious guinea pig was placed in an
airtight, custom-built, transparent plastic box consisting
of two isolated chambers: a head chamber (1600 mL
volume) and a body chamber. Pressure in the body
chamber was recorded. Cough was detected as a change
in pressure (a rapid inspiration followed by rapid expira-
tion). To disregard motion- and sneezing-related
changes in pressure, movements of the guinea pigs were
visually monitored. Cough reflex sensitivity of non-sen-
sitized or OVA-sensitized guinea pigs was measured 0.5
h after treatment with vehicle, L-NAME, or ONO1714.
Each guinea pig was initially exposed to the nebulized
10
-6 M capsaicin solution, followed by the 10
-4 Ms o l u -
tion. Solutions were inhaled for 2 min with intervals of
8 min using the DeVilbiss 646 nebulizer operated by
compressed air at 1.6 L/min (Iwaki Air Pump AP-
115AN, Iwaki Co., Ltd., Tokyo, Japan). The nebulizer
output was 0.037 mL/min. The number of coughs was
counted during 2 min inhalation of each capsaicin solu-
tion and for additional 1 min. The total number of
coughs during the 3-minute period was recorded for
each concentration of capsaicin inhaled. These proce-
dures were not performed in a blinded manner.
Exhaled NO measurement
ENO was measured by the off-line method [24]. The
expired air was sampled immediately after the measure-
ment of cough reflex sensitivity in the L-NAME experi-
ment and 24 h after the measurement (48 h after OVA
challenge) in the ONO1714 experiment. Guinea pigs
were intraperitoneally anesthetized with 75 mg/kg of
sodium pentobarbital and were placed in a supine posi-
tion. After tracheal cannulation with a polyethylene tube
(outer diameter, 2.5 mm; inner diameter, 2.1 mm), the
guinea pigs were artificially ventilated using a small ani-
mal respirator (Model 1680, Harvard Apparatus Co.,
Inc., South Natick, MA, USA) adjusted to a tidal volume
of 10 mL/kg at a rate of 60 strokes/min. The expired air
from the expiration valve of the ventilator was collected
twice in the Mylar bag for 100 s. Within 2 h after sam-
pling, the air was applied to the Sievers Model NOA280
chemiluminescence analyzer (Sievers Instruments,
Boulder, CO, USA). The analyzer was calibrated with
650 ppb NO in N2 (Taiyo Nippon Sanso Corporation,
Tokyo, Japan) according to the manufacturer’si n s t r u c -
tions. The sampling flow rate of the chemiluminescence
analyzer was 200 mL/min.
Bronchoalveolar lavage (BAL)
BAL was performed immediately after ENO sampling.
The lungs were lavaged twice through the tracheal can-
nula with 10 mL of saline (total: 20 mL). The cells in
BAL fluid (BALF) were stained with Turk’s solution and
counted in duplicate in a hemocytometer (in a Burker
chamber). Differential cell counts were performed on a
smear prepared using a cytocentrifuge and stained with
Wright-Giemsa. In our previous study using the same
experimental system, we have shown that augmentation
of cough reflex sensitivity induced by single OVA inha-
lation is preserved during 48 h in OVA sensitized guinea
pigs [23]. The procedures of anesthesia, tracheal cannu-
lation, sampling of expired gas, and BAL require consid-
erable time, which interferes with the measurement of
cough reflex sensitivity that should be performed at
scheduled time points. Therefore, we performed ENO
and BAL cell component measurements at 24 h after
the measurement of cough reflex sensitivity.
Data analysis
Statistical differences were determined using the Stu-
dent’s t-test. A P value less than 0.05 was considered
statistically significant.
Results
Because the 10
-6 M capsaicin solution elicited few
coughs in both non-sensitized and OVA-sensitized gui-
nea pigs, cough reflex sensitivity was assessed by the
number of coughs elicited by 10
-4 M capsaicin solution.
Significantly (p < 0.0001) more frequent number of
coughs was observed in OVA-sensitized guinea pigs
compared to non-sensitized guinea pigs (Figure 4, Figure
5). ENO and eosinophil counts in BALF were signifi-
cantly higher in OVA-sensitized guinea pigs compared
to non-sensitized guinea pigs (Figure 6, Figure 7, Table
1), suggesting that the OVA-induced increase in cough
reflex sensitivity may be associated with increased NO
production and eosinophil accumulation.
Experiment 1: NO depletion by the NOS inhibitor L-NAME
Figure 4 shows the effect of L-NAME on cough response
to aerosolized capsaicin in non-sensitized and OVA-sen-
sitized guinea pigs. The number of coughs induced by
the 10
-4 M capsaicin solution was significantly sup-
pressed by L-NAME in a dose-dependent manner in
both non-sensitized and OVA-sensitized guinea pigs.
ENO was also suppressed by L-NAME in both non-sensi-
tized and OVA-sensitized guinea pigs (Figure 6).
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Figure 4 Effect of L-NAME on cough reflex sensitivity, between non-sensitized and OVA-sensitized guinea pigs. L-NAME suppressed
cough reflex sensitivity to the 10
-4 M capsaicin solution in both groups dose-dependently. Each individual is presented in open circle, and the
mean value is shown as a horizontal bar. n = 6 for each group, *p < 0.05 **p < 0.01
non-sensitized guinea pigs OVA sensitized guinea pigs
**
Figure 5 Effect of ONO1714 on cough reflex sensitivity, between non-sensitized and OVA-sensitized guinea pigs. In non-sensitized
guinea pigs, there were no antitussive effects of ONO1714 observed, partial antitussive effect of ONO1714 on cough reflex sensitivity to the 10
-4
M capsaicin solution was observed in only OVA-sensitized guinea pigs. Each individual is presented in open circle, and the mean value is shown
as a horizontal bar. n = 6 for each group, **p < 0.01
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inhibitor ONO1714
F i g u r e5s h o w st h ee f f e c to fO N O 1 7 1 4o nt h ec o u g h s
induced by the 10
-4 M aerosolized capsaicin solution in
non-sensitized and OVA-sensitized guinea pigs. In non
sensitized guinea pigs, the number of coughs was not
influenced by ONO1714. On the other hand, in OVA-
sensitized guinea pigs, the number of coughs was signifi-
cantly suppressed, whereas inhibition by ONO1714 was
not dose-dependent. Further, ENO was significantly sup-
pressed by ONO1714 in both non-sensitized and OVA-
sensitized guinea pigs (Figure 7), suggesting a discre-
pancy between inhibition of cough response to capsaicin
and NO production in non-sensitized guinea pigs.
The effect of ONO1714 on BAL cell components s is
shown in Table 1. Total cell and eosinophil counts were
i n c r e a s e di nO V A - s e n s i t i z e dg u i n e ap i g sc o m p a r e dt o
non-sensitized guinea pigs. ONO1714 had no influence
on BAL cell components in any of the experimental gui-
nea pigs.
Discussion
The present study demonstrated that ENO from OVA-
sensitized guinea pigs was significantly higher than that
from non-sensitized guinea pigs; cough reflex sensitivity
to inhaled capsaicin was significantly higher as well, as
was shown in our previous study [23]. First, we
performed NOS inhibition experiment utilizing the non-
selective NOS inhibitor L-NAME, and clearly showed
the antitussive effect caused by NO depletion with L-
NAME, in both non-sensitized and OVA-sensitized gui-
nea pigs. NO seemed to be a promoter in cough reflex
sensitivity, and previous reports have pointed out the
possibility of pro-inflammatory action of NO created by
i N O S .O h u c h ie ta l[ 2 5 ]r e p o r t e dt h a ti N O Si n d u c t i o n
by endotoxin inhalation enhanced substance P-induced
microvascular leakage. Liu et al [26] examined the
effects of OVA sensitization and challenge on iNOS
gene expression in rats, and reported 3-fold increases of
iNOS mRNA in their lungs sensitized to OVA alone.
T h e r e f o r ew ec o n s i d e r e dt h a tN Op r o d u c e db yi N O S
might be a possible promoter in cough reflex sensitivity
and performed the second experiment using the selec-
tive iNOS inhibitor ONO1714, which lowered ENO
levels in both groups. ONO1714 reduced the OVA-
induced increase in cough reflex sensitivity only in sen-
sitized guinea pigs, but it did not affect the normal
cough reflex sensitivity in non-sensitized guinea pigs.
Our initial hypothesis emerged to be not supported by
these findings,
Prado et al [27] showed that OVA sensitization
enhanced the recruitment of iNOS-positive mononuclear
cells and eosinophils in guinea pigs, and that L-NAME
administration attenuated the number of mononuclear
non-sensitized guinea pigs OVA sensitized guinea pigs
** ** ** **
* * * *
Figure 6 Effect of L-NAME on ENO, between non-sensitized and OVA-sensitized guinea pigs. L-NAME suppressed ENO in both groups
dose-dependently. Each individual is presented in open circle, and the mean value is shown as a horizontal bar. n = 6 for each group, *p < 0.05
**p < 0.01
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induced pulmonary eosinophilia in OVA-sensitized mice
was significantly reduced by L-NAME, and they proposed
an eosinophil chemotactic action of NO. Thus, we
attempted to clarify the role of eosinophils, in addition to
that of NO, as a promoter of cough reflex sensitivity. In
this study, although BAL was not performed in the L-
NAME experiment, ONO1714 despite administering
twice was shown to have no inhibitory effect against BAL
eosinophilia. We speculate that at least two pathways
might be involved in cough reflex sensitivity; NO-depen-
dent and eosinophil-dependent pathways.
Our results may be explained by an idea that L-
NAME may work as a complete inhibitor of NO, while
ONO1714 gives partial suppression of NO synthesis by
exclusively inhibiting iNOS-dependent generation of
NO. And we speculate the involvement of not only NO
produced by iNOS, but also other crucial factors in
cough reflex sensitivity. Several trials have explored
whether or not NOS inhibition is effective in allergic
bronchitis. In guinea pigs, which are antigen-induced
chronic pulmonary inflammation models, cNOS inhibi-
tion causes bronchoconstriction and airway remodeling,
and selective iNOS inhibition attenuates these effects
[29]. These findings indicate that cNOS inhibition
seems to be detrimental, and iNOS inhibition is a possi-
ble target of novel therapeutic agents in bronchial
asthma. Disappointingly, Singh [30] reported that
non-sensitized guinea pigs OVA sensitized guinea pigs
** ** **
Figure 7 Effect of ONO1714 on ENO, between non-sensitized and OVA-sensitized guinea pigs. ONO1714 suppressed ENO in both groups.
Its suppression was partial in non-sensitized guinea pigs and dose-dependently in OVA-sensitized guinea pigs. Each individual is presented in
open circle, and the mean value is shown as a horizontal bar. n = 6 for each group **p < 0.01
Table 1 Bronchoalveolar lavage cell analysis
Total cells (10
5 cells/mL) Mac (%) Neu (%) Lym (%) Eos (%)
non-sensitized guinea pigs
Control 1.11 ± 0.11 71.8 ± 7.1 9.2 ± 5.6 1.8 ± 0.8 16.8 ± 5.6
ONO1714: 0.1 mg/kg 1.09 ± 0.12 74.5 ± 4.3 6.2 ± 1.5 1.4 ± 0.4 17.9 ± 4.7
ONO1714: 0.3 mg/kg 0.88 ± 0.09 76.0 ± 2.1 5.3 ± 3.3 1.5 ± 0.5 17.7 ± 1.6
OVA sensitized guinea pigs
Control 2.63 ± 0.26 24.1 ± 3.1 2.5 ± 0.6 0.9 ± 0.3 72.4 ± 3.1
ONO1714: 0.1 mg/kg 2.68 ± 0.12 25.1 ± 1.0 2.8 ± 0.3 0.5 ± 0.2 71.6 ± 1.4
ONO1714: 0.3 mg/kg 2.64 ± 0.36 28.5 ± 3.6 0.8 ± 0.3 0.8 ± 0.3 69.9 ± 3.7
BAL was performed immediately after cough reflex sensitivity in non-sensitized guinea pigs. Whereas in OVA sensitized guinea pigs, BAL was performed2 4h
after cough reflex sensitivity. MAC, macrophages; NEU, neutrophils; LYM, lymphocytes; EOS, eosinophils
Hori et al. Cough 2011, 7:5
http://www.coughjournal.com/content/7/1/5
Page 7 of 9selective iNOS inhibition effectively reduced ENO, but
did not alter airway hyperresponsiveness and inflamma-
tion. This is consistent with our present results that no
anti-inflammatory effects were observed in selective
iNOS inhibition with ONO1714. Corticosteroids, which
are clinically the most effective medication for bronchial
asthma, induce ENO depletion and suppression of air-
way eosinophilia, but have not been proved to diminish
cough reflex sensitivity.
Pharmacological therapies for cough, such as codeine,
have not made significant progress and the development
of innovative antitussive agents is expected. Transient
receptor potential cation channel, subfamily V, member
1(TRPV1) antagonists have been recognized as potential
antitussives [31]. TRPV1 is a capsaicin receptor located
in primary sensory neurons, where neuropeptides such
as substance P are colocalized [32]. Moore et al [33]
reported that an NO signaling cascade had unmasked
functional neurokinin 2 receptors in acutely isolated
nodose ganglion neurons of guinea pigs, and that NO
seemed to act in afferent pathways of cough reflex. In
this study, we could not explain the reason for partial
inhibitory effect of iNOS inhibitor in cough reflex sensi-
tivity. Therefore further studies involving other selective
iNOS inhibitors or iNOS-knocked-out animals are
needed.
Conclusions
Our results showed that L-NAME totally suppressed
cough reflex sensitivity to inhaled capsaicin and reduced
ENO in both non-sensitized and OVA-sensitized guinea
pigs. On the other hand, although ONO1714 showed a
partial suppression of cough reflex sensitivity associated
with further ENO suppression in OVA-sensitized guinea
pigs, it had no antitussive effect despite ENO suppres-
sion in non-sensitized guinea pigs. ONO1714 did not
influence BAL cell components 48 h after OVA chal-
lenge in sensitized animals. Our experiments suggest
that NO is involved in both the normal cough reflex cir-
cuit and increased cough reflex sensitivity induced by
allergic reaction. However, the pathway of involvement
is too complex to be explained by the results of the pre-
sent study. The precise mechanism of action need to be
investigated in future studies.
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